<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04548830</url>
  </required_header>
  <id_info>
    <org_study_id>20-374</org_study_id>
    <nct_id>NCT04548830</nct_id>
  </id_info>
  <brief_title>Safety of Lung Cryobiopsy in People With Cancer</brief_title>
  <official_title>Safety of Transbronchial Cryobiopsy in a Cancer Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Sloan Kettering Cancer Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to find out whether a biopsy technique called transbronchial&#xD;
      cryobiopsy (TBCB) is a safe alternative to the standard biopsy procedure (transbronchial&#xD;
      forceps biopsy; TBFB). The study researchers think that TBCB may provide better biopsy&#xD;
      samples to help diagnose lung disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 8, 2020</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This is a single center investigator initiated study for patients who display indeterminant pulmonary nodules and diffuse parenchymal lung disease on CT chest imaging who have been referred to the Pulmonary service.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post Cryobiopsy complications</measure>
    <time_frame>2 years</time_frame>
    <description>will be graded according to Common Terminology Criteria for Adverse Events version 5 (CTCAE v5)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Transbronchial cryobiopsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All study participants will undergo transbronchial biopsies via our proposed standardized cryo-biopsy protocol in place of the traditional forceps transbronchial biopsy that is typically used at MSK.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transbronchial cryobiopsy</intervention_name>
    <description>After enrollment, and pre-treatment procedures are complete, patients will undergo flexible bronchoscopy with a therapeutic bronchoscope under general anesthesia via an advanced airway at Memorial Hospital in an inpatient or outpatient setting.</description>
    <arm_group_label>Transbronchial cryobiopsy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or greater&#xD;
&#xD;
          -  Patients with known or suspected diagnosis of cancer and indeterminant pulmonary&#xD;
             nodules or diffuse parenchymal lung disease with non-diagnostic clinical profiles for&#xD;
             whom a lung biopsy is deemed useful for diagnosis.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with pulse oximetry less than 92% on oxygen delivery up to 2 L nasal cannula.&#xD;
&#xD;
          -  Uncorrectable coagulopathy defined as:&#xD;
&#xD;
               -  Platelet count &lt;50,000 x 10^9/L or&#xD;
&#xD;
               -  prothrombin time international normalized ratio &gt;1.5&#xD;
&#xD;
          -  FVC &lt;50% of the predicted value, DLCO &lt;30% of the predicted value or FEV1 &lt;0.8L&#xD;
&#xD;
          -  Known pulmonary hypertension or echocardiographic pulmonary artery systolic pressure&#xD;
             &gt;50mmHg&#xD;
&#xD;
          -  A secure diagnosis based on clinical and high-resolution CT scan data.&#xD;
&#xD;
          -  Antiplatelet therapy that cannot be held for more than 5 days.&#xD;
&#xD;
          -  Any patient deemed unfit to undergo bronchoscopy by the proceduralist&#xD;
&#xD;
          -  Female patients with a positive pregnancy test within 30 days of the planned study&#xD;
             procedure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bryan Husta, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bryan Husta, MD</last_name>
    <phone>212-639-5448</phone>
    <email>hustab@mskcc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jason Beattie, MD</last_name>
    <phone>212-639-7843</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center (All Protocol Activities)</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bryan Husta, MD</last_name>
      <phone>212-639-5448</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mskcc.org/mskcc/html/44.cfm</url>
    <description>Memorial Sloan Kettering Cancer Center</description>
  </link>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 8, 2020</study_first_submitted>
  <study_first_submitted_qc>September 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>November 12, 2021</last_update_submitted>
  <last_update_submitted_qc>November 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cryobiopsy</keyword>
  <keyword>20-374</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

